CN1137724C - Diagnosis reagent for blood cardiac muscle myosin light chain I of myocardiac infarction - Google Patents

Diagnosis reagent for blood cardiac muscle myosin light chain I of myocardiac infarction Download PDF

Info

Publication number
CN1137724C
CN1137724C CNB981220665A CN98122066A CN1137724C CN 1137724 C CN1137724 C CN 1137724C CN B981220665 A CNB981220665 A CN B981220665A CN 98122066 A CN98122066 A CN 98122066A CN 1137724 C CN1137724 C CN 1137724C
Authority
CN
China
Prior art keywords
glu
gag
light chain
aag
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB981220665A
Other languages
Chinese (zh)
Other versions
CN1225839A (en
Inventor
龚祖埙
彭宝珍
周国瑛
黄人健
曹慧婷
沈学仁
沈菊英
吴建华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institutes for Biological Sciences SIBS of CAS
Original Assignee
Shanghai Institute of Biochemistry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Biochemistry filed Critical Shanghai Institute of Biochemistry
Priority to CNB981220665A priority Critical patent/CN1137724C/en
Publication of CN1225839A publication Critical patent/CN1225839A/en
Application granted granted Critical
Publication of CN1137724C publication Critical patent/CN1137724C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention relates to a diagnostic reagent for a blood cardiac muscle myosin light chain I of acute myocardial infarction, which mainly comprises a high expression product of a human cardiac muscle myosin light chain I gene in colibacillus as positive control, and a single antibody and multiple antibodies prepared from the expression product used as an antigen. A diagnostic method is a double antibody sandwich method, namely that an antigen, namely a cardiac muscle myosin light chain I, detected in serum is captured by a single immobilized antibody, multiple antibodies are used as detection antibodies, and the onset period is judged according to the proportion of an ELISA reading value measured after an enzyme reacts with a substrate to a cut off value provided by the present invention; if the ELISA reading value is larger than the cut off value, the onset period of acute myocardial infarction is judged as truth.

Description

The blood cardiac muscle myosin light chain I diagnostic reagent of myocardial infarction
The present invention relates to the diagnostic reagent of human heart disease, especially about people's acute myocardial infarction, myocarditic new reagent for clinical diagnosis.
Cardiovascular disease is one of main disease of China, and particularly along with the increase of China resident aging degree, the mortality rate of acute myocardial infarction rises year by year, and the myocarditis case also greatly increases.At present, though the blood testing of acute myocardial infarction has clinical widely used creatine phosphokinase (CPK), lactic acid dehydrogenase (LDH) and glutamic oxaloacetic transaminase, GOT methods such as (GOT), but its early stage property, susceptiveness and persistency all can not satisfy clinical requirement, can only be suitable in two, three days after the patient falls ill, the phenomenon that causes the patient to die suddenly happens occasionally.Myocardial infarction sickness rate at home is very high, and particularly the northern area of China is much higher than south, reaches more than ten times.At present, because the raising that the increase of global aging degree has brought the cardiovascular disease incidence rate, this also provides vast market for the application of detectable.Therefore a kind of development of sensitivity, single-minded, early stage, persistent myocardial infarction detectable more becomes pressing for of domestic and international heart disease control and treatment.
Myosin is a kind of main structural protein in the muscle, plays an important role in muscle contraction, is made up of the light chain (light chain I and light chain II) that a heavy chain and two molecular weight are respectively 27KD and 20KD.Discover, because light chain in sour environment, easily dissociates from heavy chain.Early eighties, the Japan scientist at first finds, work as ischemia, when anoxia causes cardiac damage, cardiac muscular tissue's cardiac muscle myosin light chain that constantly dissociates for a long time in blood, and the direct destructive process of reflecting myocardium of variation of phasic property at that time are because people's cardiac muscle light chain I is more stable in blood, therefore can be used as of detecting heart disease new with important biochemical indicator (Yamada T.et al., Am Heart J 1998 Feb; 135 (2 Pt 1): 329-34; Hisatomi K.et al., Thorac Cardiovasc Surg 1996 Dec; 44 (6): 296-9; Ravkilde J.et al., J Am Coll Cardiol 1995 Mar1; 25 (3): 574-81; Ravkilde J.et al., Cardiology 1994; 84 (2): 135-44; Uchino T.et al., J Cardiovasc Surg 1993, Dec; 34 (6): 517-22).
Since above-mentioned theory was set up, many laboratory attempts of Europe, the United States and Japan were applied to the antibodies radioimmunoassay of people's cardiac muscle myosin light chain on the mensuration of people's myocardial infarction case, had obtained satisfied result.Yet, the external report that small-scale application in the laboratory is only arranged so far, the formal diagnostic kit of producing of Shang Weijian, trace it to its cause and mainly be: 1) myosin has suitable special nature, to from cardiac muscle, isolate the myosin of q.s and carry out fractionation light, heavy chain, must possess the theoretical basis of sturdy muscle protein research; 2) as the detection kit, people's cardiac muscle myosin light chain must be arranged as antigen control, its source is very restricted.
For this reason, the purpose of this invention is to provide a kind of blood cardiac muscle myosin light chain I diagnostic reagent of myocardial infarction, be applied in early stage property, persistence and the specificity aspect of this diagnostic reagent all are better than the detection method of use at present greatly.
Myocardial infarction blood cardiac muscle myosin light chain I provided by the invention (HCMLC I) diagnostic reagent comprises that mainly the high expressed product of people cardiac muscle myosin light chain I gene in escherichia coli is as positive control and this expression product monoclonal antibody and the multi-resistance as antigen preparation.The utilization of monoclonal antibody has improved the specificity of diagnostic reagent greatly; Replace radioimmunology with the ELISA assay method, make it not only to have higher sensitivity but also do not produce pollution, detection means is convenient and easy.
It is diagnostic method that the present invention adopts the double-antibody sandwich elisa method, with antigen---the cardiac muscle myosin light chain I in the immobilised monoclonal antibody Acquisition Detection serum, monoclonal antibody prepares the gene engineering expression product of used antigen behaviour cardiac muscle myosin light chain I, with the anti-cardiac muscle myosin light chain I of horseradish peroxidase-labeled as detecting antibody, according to the antigenic content in the change in color mensuration serum of enzyme-to-substrate reaction back, finally compare according to ELISA reading value and marginal value provided by the invention (cut off value), greater than cut off value, be judged as the period of disease of acute myocardial infarction.Be that example divides five parts that content of the present invention is described in detail in detail with Chinese's cardiac muscle myosin light chain I below.One. the preparation of the gene clone of Chinese's cardiac muscle myosin light chain I and the total RNA of sequencing 1. people cardiac muscle
Postoperative people's cardiac muscle is removed other tissue, and getting ventricular muscles is experiment material, adds the extraction buffer of pre-cooling, uses tissue mashing machine's homogenate, and centrifugal back gained supernatant phenol: chloroform: the extracting of isoamyl alcohol mixed liquor disappears until the Denatured protein layer.The acquisition precipitation was total RNA after water added dehydrated alcohol.2. the preparation of the total mRNA of people's cardiac muscle
Extractive total RNA fully mixed (vibration) rearmounted 0 ℃ of refrigerator insulation 3-4 hour with efficient Oligo (dT) cellulose or spends the night, gentle agitation or vibration mixing again after the taking-up, centrifuged deposit is collected supernatant after containing the Tris eluting of KCl, obtain to be precipitated as the total mRNA of people's cardiac muscle after adding dehydrated alcohol.3. the cDNA of people's cardiac muscle myosin light chain I makes up
Gene order (the G.Jackowski of the people's cardiac muscle myosin light chain I that delivered in 1988 according to Canadian G.Jackowski, Nucleic Acid Research, 1988), the synthetic gene 3 ' with people's cardiac muscle myosin light chain I of design is held and 5 ' end corresponding two primers (5 ' GGAATTCCTTAGCTGGACATGATGT 3 ' and 5 ' GGAATTCCATGGCCCCCAAAAAGCC3 '), and at the synthetic joint that connects restricted enzyme EcoRI simultaneously of primer.Extractive total mRNA takes out through AMV reverse transcriptase reverse transcription phenol, and ethanol precipitation obtains cDNA.4.cDNA polymerase chain reaction (PCR) amplification and clone
The pcr amplification of cDNA carries out (referring to molecular cloning operating guidance, T.Maniatis, E.F.Fritsch with above-mentioned two primers, J.Sambrook, 1989), PCR product (Fig. 1) is after restricted enzyme EcoR I hydrolysis, it is cloned the into EcoR I site of carrier puc19, check order waiting.5. the gene sequencing of people cardiac muscle myosin light chain I
Operate by the molecular cloning operating guidance of T.Maniatis with " dideoxy " mensuration of standard order, its result contains 588 bases as shown in Figure 2 altogether, and the aminoacid sequence of the HVMLC I that releases from gene order contains 195 aminoacid altogether.But the gene order of the people who delivers with Canadian G.Jackowski cardiac muscle myosin light chain I is compared, two place's differences are arranged, one place is at the 24th, become alanine by glutamic acid, another place's difference is bigger, is promptly become-Lys-Pro-arginine-glutamine by-agedoite-arginine-serine-lysine from 98 to 101 amino acids.(see figure 3) for prove this two places difference no thanks in the polymerase chain reaction resultant error cause, the present invention begins common repeated experiments twice from total mRNA extracting, and takes different heart materials, the result repeats fully.The gene that proves Chinese HVMLC1 thus has distinctive sequence fragment, and both difference is estimated relevant with the difference of ethnic group.Two. the structure and the clone of the expression of people's cardiac muscle myosin light chain I and purification 1. expression plasmids of expression product
With EcoRI it is cloned into the PCR product water of carrier puc19 and separate, the clone EcoRI site of advancing expression vector pGEX-3X is built into expression plasmid again.2. expression product induces purification
The single bacterium colony that contains expression plasmid LB (+Amp) in after the continuous culture, add IPTG and induce, 37 ℃ of overnight incubation.Centrifugal collection thalline, precipitation suspension MTPBS buffer, ultrasound wave breaks bacterium.Centrifugal behind the broken bacterium to remove cell debris, on reset and add Triton X-100 and get supernatant again after centrifugal and be splined on Glutathione Sepharose 4B post, earlier wash 10 column volumes behind the last sample with the PBS buffer, reuse Glutathion eluting just obtains the GST fusion expressed product (Fig. 4) of the people cardiac muscle myosin light chain I of purification.Three. Monoclonal Antibody 1. animal immunes of people's cardiac muscle myosin light chain I expression product
Get female mice, add isopyknic Freund's complete adjuvant with the GST fusion expressed product of the people of purification cardiac muscle myosin light chain I mice is carried out the abdominal cavity initial immunity; Three all backs add isopyknic non-Freund's complete adjuvant with the same antigen of measuring mice are carried out the abdominal cavity immunity second time; Amount with immunity for the second time after two weeks is carried out abdominal cavity immunity for the third time to mice.
Merge first three day to mice immunized antigen, do not add any adjuvant, directly inject spleen.2. merge
Myeloma cell p3x63Ag8.653 cultivates in complete culture solution, and the cell of the trophophase of taking the logarithm is used for merging.Aseptic condition takes out the spleen of immune mouse down, collects the splenocyte counting.The myeloma cell mixes with splenocyte, and centrifugal ten minutes, remove supernatant, wash cell once with non-complete culture solution, the centrifugal supernatant that eliminates of the same method, it is fast to break up cell agglutination, adds Polyethylene Glycol 4000, carries out cell fusion according to a conventional method.Fused cell adds HAT and selects culture fluid to place well culture plate to cultivate.Remove 1/2 volume cell culture fluid about 7 days, the fresh HAT that changes to 1/2 volume selects culture fluid, continues to cultivate, and treats hybridoma length to 10 5Individual when above, detect in the cell culture fluid whether contain antibody with indirect elisa method, this indirect elisa method is as described below: envelope antigen is the GST fusion expressed product of people's cardiac muscle myosin light chain I of purification, 4 ℃ are spent the night, the washing back adds culture fluid to be measured, hatches for 37 ℃, and the washing back adds the HRP-sheep anti-mouse igg, 37 ℃ of insulations add substrate H after the washing 2O 2And tetramethyl benzidine (TMB) colour developing, 450nm measures light suction degree, and OD is positive more than 0.5.3. cloning
Adopt limiting dilution assay clone positive cell, repeated cloning, till positive rate 100%, obtain the monoclonal cell strain that anti-people's cardiac muscle myosin light chain I is secreted in a strain through screening, called after HCMLC1-8 is (by the common micro-organisms center preservation of Beijing China Committee for Culture Collection of Microorganisms, on November 25th, 1998, deposit number is CGMCC NO.0370).Four. the polyclonal antibody preparation of people's cardiac muscle myosin light chain I expression product
Get male White Rabbit, add isopyknic Freund's complete adjuvant with the GST fusion expressed product of the people of purification cardiac muscle myosin light chain I White Rabbit is carried out the shank initial immunity; Three week backs add isopyknic non-Freund's complete adjuvant with the GST fusion expressed product of people's cardiac muscle myosin light chain I of purification, and that White Rabbit is carried out shank is immune for the second time; Per two week backs are carried out immunity with the amount of immunity for the second time to White Rabbit, and immunity is 4 times altogether, and the White Rabbit to immunity before the blood sampling carries out supplementary immunization, the IgG in the purified blood serum also that takes a blood sample of the White Rabbit after immunity finishes.Five. the double-antibody sandwich elisa method detects the acute myocardial infarction period of disease
With the monoclonal antibody of anti-people cardiac muscle myosin light chain I expression product (HCMLC1-8,4000 *) bag quilt, place the back of spending the night and seals with defatted milk powder; After the washing, add test serum (people's cardiac muscle myosin light chain I expression product of purification is as positive control) back insulation; Washing methods is the same, and the anti-people's cardiac muscle of the rabbit myosin light chain I multi-resistance that adds horseradish peroxidase-labeled is incubated, and the washing back adds the substrate H of horseradish peroxidase 2O 2And tetramethyl benzidine develops the color the 450nm absorbance in each hole reading on the ELISA detector.
The marginal value (cut off value) that provided in the reading of surveying and the diagnostic reagent of the present invention compare, be higher than the positive of marginal value, subcritical value negative.Advantage of the present invention and effect:
At present, be extensive use of creatine phosphokinase (CPK), lactic acid dehydrogenase (LDH) and the glutamic oxaloacetic transaminase, GOT methods such as (GOT) of the blood testing of myocardial infarction clinically, usually can only after falling ill, the patient be suitable in two, three days, its early stage property, susceptiveness and persistency all can not satisfy clinical requirement, and the phenomenon that the patient dies suddenly happens occasionally.And the diagnostic reagent that the present invention developed is compared with above-mentioned, has remarkable advantages on Clinical detection.At first be the early stage property that it detects, at 12 hours of patient's morbidity, just can detect the cardiac muscle myosin light chain I that discharges because of myocardial damage in the blood usually; Next is its susceptiveness and persistence, also is better than the detection method of using at present; Especially can in two weeks, constantly monitor patient, can prevent and treat the patient well and die suddenly, also can assess the protection and the therapeutical effect of medicine heart damage; add the specificity of its height; and,, be suitable for too as myocarditis etc. to other cardiomyopathy.Table 1 shows the comparison of carrying out with creatine phosphokinase (CPK), lactic acid dehydrogenase (LDH) and glutamic oxaloacetic transaminase, GOT methods such as (GOT).
The comparison of HCMLC-I among the table 1 acute myocardial infarction patients serum (cardiac muscle myosin light chain I) and other clinical biochemical index:
Biochemical indicator The time that occurs the earliest in the serum (hour) The time that peak value occurs (hour) Persistent period in the serum (my god)
CPK 4~6 16~24 4~5
CPK(MB) 3 18~36 2~4
GOT ~12 12~48 ~7
LDH 6 30~96 7~10
HCMLC-I 4~6 30~144 7~16
As seen from the table, during the myocardial infarction morbidity, the time that cardiac muscle myosin light chain I occurs in the serum is similar with CPK (MB) to CPK, all wants Zao than GOT and LDH, and continue to occur peak value and reach 16 days, and just can't detect about 7 days often appears in some other index.Thereby, with cardiac muscle myosin light chain I as diagnosis index, it is property in early days, susceptiveness, persistence and specificity aspect all are better than present employed detection method greatly, add that its testing process is very easy, used detecting instrument makes detectable provided by the invention have market and use value widely in various big hospital utilization already again.
Description of drawings: one. the pcr amplification product of people's cardiac muscle myosin light chain I gene
1. λ DNA Hind III standard molecular weight
2.PCR product two. the gene order of people's cardiac muscle myosin light chain I
1. the gene order of Chinese's cardiac muscle myosin light chain I
2. (the line part is identical to the gene order of people's cardiac muscle myosin light chain I of Canada's report
Sequence) three. the protein sequence of people's cardiac muscle myosin light chain I
1. the protein sequence of Chinese's cardiac muscle myosin light chain I
2. (the line part is a phase to the protein sequence of people's cardiac muscle myosin light chain I of Canada's report
Same sequence) four. the e. coli expression product of people's cardiac muscle myosin light chain I
1. standard molecular weight albumen
2. the e. coli expression product of people cardiac muscle myosin light chain I
The gene clone of embodiment 1. people cardiac muscle myosin light chain I and the preparation of the total RNA of sequencing 1. people cardiac muscle
Postoperative people's cardiac muscle is removed other tissue, and getting 10 gram ventricular muscles is experiment material, adds extraction buffer (0.02M Tris-HCl pH8.9,0.5%SDS, 0.04M NaCl, the 0.005M MgCl of 6 times of volumes of pre-cooling 2), use tissue mashing machine's homogenate, every homogenate one time one minute, paused one minute, triplicate, with 12000rpm/ minute, centrifugal 10 minutes, reset and add the phenol of 2 times of volumes on the gained: chloroform: the isoamyl alcohol mixed liquor, contain 0.2%SDS, 0.01M EDTA vibration 10 minutes, 10000rpm/ minute, centrifugal 10 minutes, supernatant repeated to disappear until the Denatured protein layer with this mixed liquor extracting.Water adds the dehydrated alcohol of 2.5 volumes, 1/10 volume 3M NaAc, and pH5.4 ,-70 ℃ of placements are spent the night.Centrifugal, 15000rpm/ minute, centrifugal 20 minutes, precipitation washed twice with 70% cold ethanol, and 15000rpm/ minute, centrifugal 5 minutes, precipitation was total RNA, drains stand-by.2. the preparation of the total mRNA of people's cardiac muscle
The total RNA of 4mg is dissolved in the aseptic redistilled water of 2ml in ice bath, add 0.5ml 2.5M KCl, 0.05M Tris-HCl, pH7.5 buffer.Get the efficient Oligo of 0.1g (dT) cellulose (magnificent company) and place beaker, remove buffer with inhale after the 0.5M KCl 0.01M Tris-HCl pH7.5 buffer soaked overnight as far as possible.Above-mentioned total rna solution is added in Oligo (dT) the cellulose buffer, and fully the rearmounted 0 ℃ of refrigerator of mixing (vibration) is incubated 3-4 hour or spends the night.Gentle agitation or vibration mixing again after the taking-up, 4 ℃ are centrifugal, and 6000rpm/ minute, centrifugal 5 minutes, precipitation was used 0.5M KCl, and 0.01M Tris-HCl washs to supernatant A 260nm<0.03, use 0.01MTris-HCl again instead, pH7.5 is centrifugal after the washing precipitation in 54 ℃, collect supernatant, a little buffer of precipitation reuse is incubated 5 minutes in 54 ℃, centrifugal, merges the secondary supernatant, 2%NaCl 95% ethanol that adds 2.5 times of pre-coolings again, put-20 ℃ and spend the night centrifugally, precipitation is used ice-cold 2%NaCl, 75% washing with alcohol, precipitate is put after vacuum drains residual liquid, is dissolved in the total mRNA of the popular flesh of a small amount of aseptic redistilled water.3. the cDNA of people's cardiac muscle myosin light chain I makes up
The gene order of the people's cardiac muscle myosin light chain I that delivered in 1988 according to Canadian G.Jackowski, two primers have been synthesized in design, and at the synthetic joint that connects restricted enzyme EcoRI simultaneously of primer, it is in proper order: primer I: 5 ' GGAATTCCTTAGCTGGACATGATGT 3 ', and it holds 17 nucleotide sequence complementations with the gene 3 ' of people's cardiac muscle myosin light chain I; Primer I I:5 ' GGAATTCCATGGCCCCCAAAAAGCC 3 ', it is identical with 17 nucleotide sequences of gene 5 ' end of people's cardiac muscle myosin light chain I.
Get the extractive total mRNA of 10 μ l (5 μ g/ μ l), 2 μ l primer Is (1 μ g/ μ l), 7 μ l 5x AMB virus (AMV) buffer, 1 μ l RNasin (10unit/ μ l), 8 μ l, 4 * dNTP (each 10m mol), 4 μ l H 2O adds 3 μ l AMV reverse transcriptases again, and 42 ℃, 105 minutes, add 2.1 μ l 10N NaOH, 37 ℃, 30 ', 1.8 μ l 12N HCl neutralization separates through Sephadex G-50, removes micromolecule template and unnecessary dNTP, takes out through phenol, and ethanol precipitation gets cDNA.4.cDNA polymerase chain reaction (PCR) amplification and clone
The pcr amplification of cDNA is undertaken by the molecular cloning operating guidance of T.Maniatis.
Contain 63 μ l ddH in the reactant liquor 2O, 10 μ l, 10 * Taq buffer, 16 μ l dNTP (each 2.5m mol), 2 μ l primer Is (1 μ g/ μ l), 2 μ l primer I I (1 μ g/ μ l), 6 μ lcDNA strands (9.6ng), 1 μ l Taq archaeal dna polymerase (5unit) adds 100 μ l liquid petrolatums after mixing, and reacts by following program:
Degeneration annealing is synthetic
94℃ 55℃ 72℃
Circulation I 5 ' 2 ' 3 '
The circulation 2 to following 24 1 ' 2 ' 3 '
' 2 ' 6 of circulating 25 1 '
Behind the reaction back sucking-off petrolatum, get 10 μ l and identify (Fig. 1) with 1.5% sepharose electrophoresis, remaining sample is ethanol precipitation after the phenol extracting.
The PCR product is cloned the into EcoR I site of carrier puc19 (magnificent company) according to the molecular cloning experiment guide of T.Maniatis etc. with it after restricted enzyme EcoR I hydrolysis, check order waiting.5. the gene sequencing of people cardiac muscle myosin light chain I
With " dideoxy " mensuration of standard order (referring to the molecular cloning operating guidance of T.Maniatis etc.), its result contains 588 bases as shown in Figure 2 altogether, and the aminoacid sequence of the HVMLC I that releases from gene order contains 195 aminoacid altogether.But compare with the gene order of people's cardiac muscle myosin light chain I of Canadian G.Jackowski report, two place's differences are arranged, one place is at the 24th, become alanine by glutamic acid, another place's difference is bigger, is promptly become-Lys-Pro-arginine-glutamine by-agedoite-arginine-serine-lysine from 98 to 101 amino acids.(see figure 3) for prove this two places difference no thanks in the polymerase chain reaction resultant error cause, the present invention begins common repeated experiments twice from total mRNA extracting, and takes different heart materials, the result repeats fully.The gene that proves Chinese HVMLC1 thus has distinctive sequence fragment, and both difference is estimated relevant with the difference of ethnic group.Embodiment 2: the structure and the clone of the expression of people's cardiac muscle myosin light chain I and purification 1. expression plasmids of expression product
With EcoRI it is cloned into the PCR product water of carrier puc19 and separate, the clone EcoRI site of advancing expression vector pGEX-3X (magnificent company) is built into expression plasmid again.2. expression product induces purification
The single bacterium colony that contains expression plasmid 2ml LB (+cultivate in Amp), 37 ℃ are spent the night.Change 1ml37 ℃ above-mentioned spend the night bacterium in 50ml LB (+cultivate in Amp), 37 ℃ spend the night after, change again 50ml37 ℃ above-mentioned spend the night bacterium in 500ml LB (+Amp) in, cultivated 3 hours, and in culture fluid, added 1.25ml IPTG (100m mol), 37 ℃ of overnight incubation for 37 ℃.
Centrifugal 6,000rpm collected thalline in 10 minutes, and precipitation is with MTPBS buffer (150m molNaCl, 16m mol Na 2HPO 4, 4m mol NaH 2PO 4) being suspended in the 40mlMTPBS buffer after washing once, ultrasound wave breaks bacterium.Add the MTPBS buffer to 200ml behind the broken bacterium, centrifugal 10,000rpm, 20 minutes removing cell debris, on reset and add Triton X-100 to final concentration be 1%, centrifugal 10,000rpm, 10 minutes; Get the GlutathioneSepharose 4B post that supernatant is splined on 2ml, earlier wash 10 column volumes behind the last sample with the PBS buffer, reuse 10m molGlutathion 50m mol Tris-HCl, the pH8.0 eluting just obtains the GST fusion expressed product (Fig. 4) of the people cardiac muscle myosin light chain I of purification.Embodiment 3: Monoclonal Antibody 1. animal immunes of people's cardiac muscle myosin light chain I expression product
Get female BalB/C mice (5-7 week age), add isopyknic Freund's complete adjuvant with the GST fusion expressed product (50g/) of people's cardiac muscle myosin light chain I of purification mice is carried out the abdominal cavity initial immunity; Three all backs add isopyknic non-Freund's complete adjuvant with the same antigen of measuring mice are carried out the abdominal cavity immunity second time; Amount with immunity for the second time after two weeks is carried out abdominal cavity immunity for the third time to mice.
Merge first three day to the antigen of immune BalB/C mice, do not add any adjuvant, directly inject spleen with 50 μ g/.2. merge
Myeloma cell p3x63Ag8653 cultivates in complete culture solution, and the cell of the trophophase of taking the logarithm is used for merging.Aseptic condition takes out the spleen of immune mouse down, collects the splenocyte counting.Myeloma cell and splenocyte were with 1: 5 mixed, and 1000rpm centrifugal ten minutes removes supernatant, washes cell once with non-complete culture solution, the centrifugal supernatant that eliminates of the same method, and it is fast to break up cell agglutination, adds 50% Macrogol 4000 and carries out cell fusion.Fused cell adds HAT and selects culture fluid to place well culture plate (~10 5Individual cells/well) cultivates.Remove 1/2 volume cell culture fluid about 7 days, the fresh HAT that changes to 1/2 volume selects culture fluid, continues to cultivate, and treats hybridoma length to 10 5Individual when above, detect in the cell culture fluid whether contain antibody with indirect elisa method.This indirect elisa method is as described below:
Envelope antigen is the GST fusion expressed product (10 μ g/ml) of people's cardiac muscle myosin light chain I of purification, the every hole of 96 hole ELISA Plate adds 50 μ l, 4 ℃ are spent the night, the washing back adds culture fluid to be measured, hatched 1 hour for 37 ℃, the washing back adds the HRP-goat-anti and belongs to IgG, and 37 ℃ are incubated 30 minutes, add substrate H after the washing 2O 2And the TMB colour developing, 450nm measures light suction degree, and OD is positive more than 0.5.3. cloning
Adopt limiting dilution assay clone positive cell, repeated cloning till positive rate 100%, obtains the monoclonal cell strain that anti-people's cardiac muscle myosin light chain I is secreted in a strain, name HCMLC1-8 through screening.Embodiment 4: the polyclonal antibody preparation of people's cardiac muscle myosin light chain I expression product
Get male White Rabbit (5-7 week age), add isopyknic Freund's complete adjuvant with the GST fusion expressed product (100 μ g/) of people's cardiac muscle myosin light chain I of purification White Rabbit is carried out the shank initial immunity; Three week backs add isopyknic non-Freund's complete adjuvant with the GST fusion expressed product (100 μ g/ only) of people's cardiac muscle myosin light chain I of purification, and that White Rabbit is carried out shank is immune for the second time; Per two week backs are carried out immunity with the amount of immunity for the second time to White Rabbit, and immunity is 4 times altogether, and the White Rabbit to immunity before the blood sampling carries out supplementary immunization with 100 μ g/ amount only, the IgG in its serum of purification also that takes a blood sample of the White Rabbit after the immunity end.Embodiment 5: the double-antibody sandwich elisa method detects the acute myocardial infarction period of disease
With the monoclonal antibody of the anti-people cardiac muscle myosin light chain I expression product of 5 μ g/ml (HCMLC1-8,4000 *) bag quilt, after 4 ℃ of placements were spent the night, the defatted milk powder with 5% sealed 1 hour for 37 ℃; It is inferior to give a baby a bath on the third day after its birth through cleaning mixture (0.27%Tween 20 for 20mmol Tris, 45mmol HCl), and each 5 minutes, add test serum (people's cardiac muscle myosin light chain I expression product of purification is as positive control), 37 ℃ are incubated 1 hour; Washing methods is the same, adds the anti-people's cardiac muscle of the rabbit myosin light chain I multi-resistance of horseradish peroxidase-labeled, and 37 ℃ are incubated 45 minutes, wash five times with above-mentioned cleaning mixture, add the substrate H of horseradish peroxidase at last 2O 2And tetramethyl benzidine develops the color the 450nm absorbance in each hole reading on the ELISA detector.
The marginal value (cut off value) that provided in the reading of surveying and the diagnostic reagent of the present invention compare, be higher than the positive of marginal value, subcritical value negative.

Claims (3)

1, a kind of blood cardiac muscle myosin light chain I diagnostic reagent of myocardial infarction is characterized in that this diagnostic reagent comprises that mainly the high expressed product of Chinese's cardiac muscle myosin light chain I gene in escherichia coli is as positive control and this expression product monoclonal antibody and the multi-resistance as antigen preparation.
2、1,I:ATG GCC CCC AAA AAG CCA GAG CCC AAG AAG GAT GAT GCC AAG GCA GCC CCC AAG GCA GCT 60CCA GCT CCC GCA CCT CCC CCT GAG CCT GAG CGC CCT AAG GAG GTC GAG TTT GAT GCT TCC 120AAG ATC AAG ATT GAG TTC ACA CCT GAG CAG ATT GAA GAG TTC AAG GAA GCC TTC ATG CTG 180TTC GAG CGC ACA CCC AAG TGT GAG ATG AAG ATC ACC TAC GGG CAG TGT GGG GAT GTC CTG 240CGG GCG CTG GGC CAG AAC CCC ACA CAG GCA GAA GTG CTC CGT GTC CTG GGG AAG CCA AGA 300CAG GAA GAG CTC AAT ACC AAG ATG ATG GAC TTT GAA ACT TTC CTG CCT ATG CTC CAG CAC 360ATT TCC AAG AAC AAG GAC ACA GGC ACC TAT GAG GAC TTC GTG GAG GGG CTG CGG GTC TTC 420GAC AAG GAG GGC AAT GGC ACT GTC ATG GGT GCT GAG CTT CGC CAC GTG CTG GCC ACG GTG 480GGT GAG AGG CTG ACA GAA GAC GAA GTG GAG AGG TTG ATG GCT GGG CAA GAG GAC TCC AAT 540GGC TGC ATC AAC TAT GAA GCA TTT GTG AAG CAC ATC ATG TCC AGC TAA 588Met Ala Pro Lys Lys Pro Glu Pro Lys Lys Asp Asp Ala Lys Ala Ala Pro Lys Ala Ala 20Pro Ala Pro Ala Pro Pro Pro Glu Pro Glu Arg Pro Lys Glu Val Glu Phe Asp Ala Ser 40Lys Ile Lys Ile Glu Phe Thr Pro Glu Gln Ile Glu Glu Phe Lys Glu Ala Phe Met Leu 60Phe Asp Arg Thr Pro Lys Cys Glu Met Lys Ile Thr Tyr Gly Gln Cys Gly Asp Val Leu 80Arg Ala Leu Gly Gln Asn Pro Thr Gln Ala Glu Val Leu Arg Val Leu Gly Lys Pro Arg 100Gln Glu Glu Leu Asn Thr Lys Met Met Asp Phe Glu Thr Phe Leu Pro Met Leu Gln His l20Ile Ser Lys Asn Lys Asp Thr Gly Thr Tyr Glu Asp Phe VaI Glu Gly Leu Arg Val Phe 140Asp Lys Glu Gly Asn Gly Thr Val Met Gly Ala Glu Leu Arg His Val Leu Ala Thr Leu 160Gly Glu Arg Leu Thr Glu Asp Glu Val Glu Lys Leu Met Ala Gly Gln Glu Asp Ser Asn 180Gly Cys Ile Asn Tyr Glu Ala Phe Val His Ile Met Ser Ser 195
3, diagnostic reagent as claimed in claim 1 or 2 is characterized in that the monoclonal antibody of people's cardiac muscle myosin light chain I gene expression product is cell strain of monoclonal antibody HCMLC1-8, and its preserving number is CGMCC NO.0370.
CNB981220665A 1998-12-04 1998-12-04 Diagnosis reagent for blood cardiac muscle myosin light chain I of myocardiac infarction Expired - Fee Related CN1137724C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB981220665A CN1137724C (en) 1998-12-04 1998-12-04 Diagnosis reagent for blood cardiac muscle myosin light chain I of myocardiac infarction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB981220665A CN1137724C (en) 1998-12-04 1998-12-04 Diagnosis reagent for blood cardiac muscle myosin light chain I of myocardiac infarction

Publications (2)

Publication Number Publication Date
CN1225839A CN1225839A (en) 1999-08-18
CN1137724C true CN1137724C (en) 2004-02-11

Family

ID=5227549

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB981220665A Expired - Fee Related CN1137724C (en) 1998-12-04 1998-12-04 Diagnosis reagent for blood cardiac muscle myosin light chain I of myocardiac infarction

Country Status (1)

Country Link
CN (1) CN1137724C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116410310B (en) * 2022-08-19 2023-10-27 北京普恩光德生物科技开发有限公司 anti-CMLC-1 monoclonal antibody 8A3 and application thereof

Also Published As

Publication number Publication date
CN1225839A (en) 1999-08-18

Similar Documents

Publication Publication Date Title
DK175703B1 (en) Human tissue factor-related DNA segments, polypeptides and antibodies, hybridomas, assay methods, diagnostic systems and methods, isolation methods and manufacturing methods
JP4085114B2 (en) Novel chemokines expressed in inflammatory adenoids and their production and use
JPH10276778A (en) Diagnostic system using monoclonal antibody against cell surface receptor-ligand complex, production of the monoclonal antibody, and assay using the monoclonal antibody
JPH11507840A (en) Peanut allergens and methods
US5589358A (en) Ileal bile acid transporter compositions and methods
WO1991016428A1 (en) Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis
US5324630A (en) Methods and compositions for diagnosing lyme disease
CN110218250A (en) A kind of preparation method of grass carp component 5 polyclonal antibody
Lahiri et al. A cDNA clone of the hnRNP C proteins and its homology with the single-stranded DNA binding protein UP2
Chamekh et al. Diagnostic value of a synthetic peptide derived from Echinococcus granulosus recombinant protein.
ES2216176T3 (en) CHEMIOQUINES OF MAMMALS.
CN1137724C (en) Diagnosis reagent for blood cardiac muscle myosin light chain I of myocardiac infarction
JPH11503030A (en) Mammalian CX3C chemokine gene
US5643778A (en) RNA editing enzyme and methods of use thereof
WO1999003994A1 (en) Suppressors of cytokine signaling socs16; related reagents
US7595059B2 (en) Methods and compositions for detecting larval Taenia solium with a cloned diagnostic antigen
JPH07502883A (en) Novel cyclophilins, related proteins and uses
CN1017349B (en) Monoclonal antibodies against atrial, natriuretic peptides of humans
KR19990071959A (en) Antigenic Protein Derived from Malassezia
Kim et al. Molecular cloning and characterization of an antigenic protein with a repeating region from Clonorchis sinensis
JPH10512154A (en) Novel chemokine expressed in pancreas
CN1247615C (en) Purification of human myocardium troponin I and preparation method of its monoclonal anti-body
KR100670403B1 (en) Method for assaying creatine kinase isozyme activity and assay reagent
US7544485B2 (en) Baldness related gene and the polypeptide encoded thereby, and uses
WO1994020536A1 (en) Methods, compositions, and kits for diagnosing lyme disease

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: SHANGHAI INST. OF LIFE SCIENCE, CAS

Free format text: FORMER NAME OR ADDRESS: SHANGHAI INST. OF BIOCHEMISTRY, CHINESE ACADEMY OF SCIENCES

CP03 Change of name, title or address

Address after: 200031 No. 320, Yueyang Road, Shanghai

Patentee after: Shanghai Institute of life Sciences, Chinese Academy of Sciences

Address before: 200031 No. 320, Yueyang Road, Shanghai

Patentee before: Shanghai Research Institute of Biochemistry Chinese Academy of Sciences

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040211

Termination date: 20101204